Association of interleukin-6 polymorphism (-634C/G) in the promoter region with diabetic nephropathy in type 2 diabetes mellitus

Authors

  • Rakshanda Talib Department of Immunology, University of Health Sciences, Lahore, Pakistan
  • Muhammad Kashif Department of Immunology, University of Health Sciences, Lahore, Pakistan
  • Romeeza Tahir Department of Immunology, University of Health Sciences, Lahore, Pakistan
  • Nadeem Ahmed Department of Immunology, University of Health Sciences, Lahore, Pakistan
  • Saba Khaliq Department of Immunology, University of Health Sciences, Lahore, Pakistan
  • Bushra Mubarik Department of Immunology, University of Health Sciences, Lahore, Pakistan
  • Afia Abbas Department of Immunology, University of Health Sciences, Lahore, Pakistan
  • Shah Jahan Department of Immunology, University of Health Sciences, Lahore, Pakistan
  • Nadeem Afzal Department of Immunology, University of Health Sciences, Lahore, Pakistan

DOI:

https://doi.org/10.3329/bjms.v18i4.42878

Keywords:

Association of interleukin, 6 polymorphism, diabetes mellitus

Abstract

Background:Long term microvascular complications of DM includes: nephropathy, retinopathy, and neuropathy. Increased level of IL-6 and its polymorphism have been associated with diabetic nephropathy.The present study was designed to determine serum level of IL-6 and C/G polymorphism at − 634 position in the promoter region of IL-6 gene in patients with type 2 diabetes mellitus (T2DM) with and without nephropathy.

Method: This comparative study was comprised of 164 subjects, divided into two groups of 82 subjects in each. The subjects who had diabetes for more than 5 years without nephropathy were labeled as group-I and the subjects who had diabetes for more than 5 years with nephropathy were labeled as group-II. IL-6 polymorphism was detected by RFLP and its level was determined by ELISA technique. Data was analyzed using SPSS 20.0.

Results: In group-I, 14 (17.1%) patients had CC, 47 (57.3%) had CG and 21 (25.6%) had GG polymorphism. In group-II, 9 (11%) patients had CC, 69 (84.1%) had CG and 4 (4.9%) had GG polymorphism. Pearson’s correlation test determined significant association of IL-6 polymorphism (CC,CG,GG) in both the groups (p <0.001). In patients of CC polymorphism, median levels of IL-6 was high in group-I (4.2) as compared to group-II (3.2),whereas in patients of CG polymorphism, median levels of IL-6 was high in group-II (3.8) as compared to group I (3.7) while in GG polymorphism, median levels of IL-6 was same in both the groups. On comparison of IL-6 polymorphism and level of IL-6 there was no statistically significant difference between the two groups (p1=0.304, p2=0.425 respectively).

Conclusions: Statistically significant difference in the frequencies of allele (CC,CG,GG) between two groups is pointing towards the protective role of GG allele as it was predominant in T2DM patients without nephropathy.

Bangladesh Journal of Medical Science Vol.18(4) 2019 p.741-747

Downloads

Download data is not yet available.
Abstract
33
PDF
41

Downloads

Published

2019-08-30

How to Cite

Talib, R., Kashif, M., Tahir, R., Ahmed, N., Khaliq, S., Mubarik, B., Abbas, A., Jahan, S., & Afzal, N. (2019). Association of interleukin-6 polymorphism (-634C/G) in the promoter region with diabetic nephropathy in type 2 diabetes mellitus. Bangladesh Journal of Medical Science, 18(4), 741–747. https://doi.org/10.3329/bjms.v18i4.42878

Issue

Vol. 18 No. 4 (2019)

Section

Original Articles

License

Authors who publish in the Bangladesh Journal of Medical Science agree to the following terms that:

  1. Authors retain copyright and grant Bangladesh Journal of Medical Science the right of first publication of the work.

  2. Creative Commons Licence
    Articles in Bangladesh Journal of Medical Science are licensed under a Creative Commons Attribution 4.0 International License CC BY-4.0.This license permits use, distribution and reproduction in any medium, provided the original work is properly cited.
  3. Authors are able to enter into separate, additional contractual arrangements for the distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  4. Authors are permitted to post their work online (e.g., in institutional repositories or on their website) as it can lead to productive exchanges, as well as greater citation of published work.